Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-10-2022 | Kidney Transplantation | Case report

Immunosuppressants/valganciclovir

Leukopenia and lack of efficacy: 2 case reports

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Schaenman J, et al. Early cytomegalovirus DNAemia and antiviral dose adjustment in high vs intermediate risk kidney transplant recipients. Transplant Infectious Disease 23: No. 1, Feb 2021. Available from: URL: http://doi.org/10.1111/tid.13457 Schaenman J, et al. Early cytomegalovirus DNAemia and antiviral dose adjustment in high vs intermediate risk kidney transplant recipients. Transplant Infectious Disease 23: No. 1, Feb 2021. Available from: URL: http://​doi.​org/​10.​1111/​tid.​13457
Metadata
Title
Immunosuppressants/valganciclovir
Leukopenia and lack of efficacy: 2 case reports
Publication date
01-10-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-26572-0

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Thioctic-acid

Case report

Tozinameran

Case report

Multiple drugs